Multi- and inter-disciplinary science in personalized delivery of stem cells for tissue repair

Current Stem Cell Research and Therapy

Volumn 4, Issue 1, 2009, Pages 16-22

  Heinrich, Andrew C ^a   Patel, Shyam A ^a,b   Reddy, Bobby Y ^a   Milton, Russell ^a   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Aging; Cancer; Cytokines; Mesenchymal stem cells; Neurons; REST

Indexed keywords

AURORA A KINASE; CHECKPOINT WITH FORKHEAD AND RING FINGER DOMAIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CHFR PROTEIN, HUMAN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RE1 SILENCING TRANSCRIPTION FACTOR; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TUMOR PROTEIN;

BINDING SITE; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CLINICAL EFFECTIVENESS; DEGENERATIVE DISEASE; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC STABILITY; IMMUNE RESPONSE; MESENCHYMAL STEM CELL; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SAFETY; STEM CELL TRANSPLANTATION; TISSUE REPAIR; TUMOR VASCULARIZATION; CELL CYCLE; CELL TRANSFORMATION; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTERDISCIPLINARY COMMUNICATION; METABOLISM; METHODOLOGY; NERVE CELL; PATHOLOGY; TISSUE REGENERATION;

CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; GUIDED TISSUE REGENERATION; HUMANS; INFLAMMATION; INTERDISCIPLINARY COMMUNICATION; MESENCHYMAL STEM CELLS; NEOPLASM PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; NF-KAPPA B; REPRESSOR PROTEINS;

EID: 65249114021     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488809787169075     Document Type: Review

References (28)

1. Tang N, Song WX, Luo J, Haydon RC, He TC. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 2008; 466: 2114-30.
2. Privette LM, Weier JF, Nguyen HN, Yu X, Petty EM. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint. Neoplasia 2008; 10: 643-52.
3. Trzaska KA, Reddy BY, Munoz JL, Li KY, Ye JH, Rameshwar P. Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci 2008; 39: 285-90.
4. Westbrook TF, Hu G, Ang XL, et al. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 2008; 452: 370-4.
5. Kundu JK, Surh YJ. Inflammation: Gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
6. Weissman AM. How Much Rest is Enough? Cancer Cell 2008; 13: 381-83.
7. Greco SJ, Zhou C, Ye JH, Rameshwar P. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 2007; 16: 811-26.
8. Greco SJ, Smirnov SV, Murthy RG, Rameshwar P. Synergy between the RE-1 silencer of transcription and NF-κB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J Biol Chem 2007; 282: 30039-50.
9. Guardavaccaro D, Frescas D, Dorrello NV, et al. Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature 2008; 452: 365-9.
10. Katsanos GS, Anogeianaki A, Orso C, et al. Impact of substance P on cellular immunity. J Biol Regul Homeost Agents 2008; 22: 93-8.
11. Corcoran KE, Trzaska KA, Fernandes H, et al. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS ONE 2008 Jun 25; 3(6): e2563.
12. Greco SJ, Rameshwar P. Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J Immunol 2007; 179: 3342-50.
13. Greco SJ, Rameshwar P. MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci 2007; 104: 15484-9.
14. Sun J, Ramnath RD, Zhi L, Tamizhselvi R, Bhatia M. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 2008; 294: C1586-96.
15. Yu X, Minter-Dykhouse K, Malureanu L, et al. Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 2005; 37: 401-6.
16. Dowdy SC, Jiang S, Zhou XC, et al. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Mol Cancer Ther 2006; 5: 2767-76.
17. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008; 10: 1883-94.
18. Narayanan NK, Nargi D, Horton L, Reddy BS, Bosland MC, Narayanan BA. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: Preventive effects of celecoxib. Prostate 2008.
19. Wei LH, Kuo ML, Chen CA, et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene 2001; 20: 5799-809.
20. Hinrichs CS, Spolski R, Paulos CM, et al. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 2008; 111: 5326-33.
21. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Aging Dev 2008; 129: 163-73.
22. Cho KJ, Trzaska KA, Greco SJ, et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 2005; 23: 383-91.
23. Popp FC, Piso P, Schlitt HJ, Dahlke MH. Therapeutic potential of bone marrow stem cells for liver diseases. Curr Stem Cell Res Ther 2006; 1: 411-8.
24. Patel SA, Sherman L, Jessian Munoz, Rameshwar P. Immunological properties of Mesenchymal Stem Cells and clinical implications. J Arch Immunol Ther Exp 2008; 57: 1-8.
25. Deng J, Petersen BE, Steindler DA, Jorgensen ML, Laywell ED. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006; 24: 1054-64.
26. Ling L, Ni Y, Wang Q, et al. Transdifferentiation of mesenchymal stem cells derived from human fetal lung to hepatocyte-like cells. Cell Biol Int 2008; 32: 1091-8.
27. Olanow CW, Obeso JA, Stocchi F. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nat Clin Pract Neurol 2006; 2: 382-392.
28. Rajgopal J. Stem cell therapy - A panacea for all ills? J Postgrad Med 2005; 51: 161-163.